Surrozen (SRZN) - Rasio rega marang prakiraan pendapatan

surrozen.com (SRZN) - logo korporat

The expected P/S ratio confirms market optimism regarding the prospects of Surrozen, Inc. (SRZN). High authority in creating antibodies for regeneration and the development of organ restoration methods without transplantation ensure brand resilience. The innovative Wnt-pathway platform strengthens investor confidence, while 36.10 serves as the current metric value, capturing the real-time market valuation of the company's potential.

SRZN (surrozen.com) riwayat Rega mangsa ngarep marang pendapatan saka 02.04.2023 nganti 13.11.2026

Surrozen Inc. - rincian analitis lan metrik utama (SRZN)

- rega pasar lan target rega analis:
Bagan rega Surrozen|SRZN - Konsensus nilai wajar
- indikator kapitalisasi pasar:
Nilai pasar Surrozen Inc.|SRZN - Total Nilai Perusahaan
- indikator nilai buku ekuitas:
Nilai Akuntansi saben Saham Surrozen|SRZN - Nilai Aset Bersih|Rasio Kapitalisasi Pasar marang Nilai Buku surrozen.com|SRZN - Aset Perusahaan
- data utang lan likuiditas:
Utang marang Ekuitas Surrozen, Inc.|SRZN - Rasio utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Surrozen, Inc.|SRZN - Kewajiban utang agregat|Utang-utang marang kapitalisasi buku Surrozen Inc.|SRZN - Gunggunge utang jangka dawa|Utang jangka cendhak perusahaan Surrozen|Rasio cepet surrozen.com
- indikator pendapatan resik lan kelipatan nilai:
SRZN - Penghasilan resik|Bathi mangsa ngarep Surrozen, Inc.|SRZN - Periode bali modal bisnis|Rega marang bathi mangsa ngarep Surrozen Corp|SRZN - Kapitalisasi marang bathi resik kanthi nimbang wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Surrozen Inc.|SRZN - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan Surrozen|SRZN - Bathi saben siji saham sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan surrozen.com|SRZN - Wutah bathi saben saham ing taun iki|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Surrozen, Inc.
- informasi babagan volume dodolan lan pendapatan:
SRZN - Pendapatan reged perusahaan|Volume dodolan mangsa ngarep perusahaan Surrozen|SRZN - Kapitalisasi marang volume dodolan|Multiplikator Forward P/S Surrozen Inc.
Ringkesan analisis perusahaan:Surrozen SRZN
Produk asli surrozen.com

This indicator measures the market value of the business relative to projected annual sales, reflecting the extent to which investor expectations for future cash flows are priced in. By analyzing the projected price-to-sales ratio, one can assess the speculative premium attached to the valuation of Surrozen, Inc. (SRZN), whose current revenues depend on funding for research and development in tissue regeneration.

Analisis perusahaan pesaing

Rasio rega marang prakiraan pendapatan Mesoblast MESO|Rega forward marang dodolan LCTX|CCEL - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep FibroBiologics, Inc.|LGVN (Longeveron Inc.) - Multiplikator forward rega marang pendapatan|Rega mangsa ngarep marang pendapatan BRTX (BioRestorative Therapies, Inc.)|CELZ (Creative Medical Technology Holdings, Inc.) - Multiplikator Forward P/S